Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erzhi Tiangui Granules in Advanced-age Women With Poor Ovarian Response Undergoing IVF
NCT05698550Completed
- Sponsor
- Shandong University of Traditional Chinese Medicine
- Start
- Sep 2023
- Primary completion
- Jun 2025
- Modality
- HM (Herbal Medicine), Dietary Supplement
- Countries
- 1
01
Overview
Randomised, double-blind trial of erzhi tiangui in female infertility (2 arms), sponsored by Shandong University of Traditional Chinese Medicine. Primary endpoints: Cumulative live birth rate at 18 months and Number of oocyte retrieved at 1 month. Started Sep 2023; status: completed.
02
Drugs
erzhi tiangui
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT05698550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05698550.